Fair Value Calculator Fair Value Calculator
EN DE

2372 (2372) Fair Value & Analysis

Consumer Defensive · Market cap HK$1.0B

2 2372 2372 · HK
PriceHK$1.11
Fair ValueHK$0.3400
Upside-69.4%
Quality75/100
Watch 2372 for free — get notified when fair value or trend changes. Watch for free
Evidence: Low Range HK$0.2700 – HK$0.4000

Fair value as of: Jul 2, 2026

From 7 valuation models · updated today

Share price +88.1% over the past month.

Price vs Fair Value (12 months)

HK$1.11 HK$0.1910 Fair Value HK$0.3400 Jun 2025 Jul 2026

12‑month range HK$0.1910 – HK$1.11 · fair‑value band HK$0.2700 – HK$0.4000 · the HK$1.11 price screens above the HK$0.3400 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

2372 (2372) currently trades at HK$1.11, while our model-based Fair Value estimate is HK$0.3400 — implying the stock looks roughly 69.4% overvalued today. We read business quality at 75/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, 2372 generated revenue of HK$106M at a net margin of -3.9%. Revenue grew 9.6% year over year. It earns a return on equity of -2.0%. The balance sheet holds a net cash position of HK$85.0M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$106M
Revenue growth (YoY) +9.6%
Net margin -3.9%
Return on equity -2.0%
Free cash flow HK$36.7M FY2025
Operating margin -10.2%
More key figures
EPS growth (YoY) -73.8%
Net cash HK$85.0M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

2372 reported revenue of HK$106M in FY2025 versus HK$370M in FY2021, a compound −26.9%/yr. Reported net income was −HK$4.1M in FY2025.

Revenue −26.9%/yr
FY21 HK$370M
FY22 HK$289M
FY23 HK$191M
FY24 HK$112M
FY25 HK$106M
Net income
FY21 HK$35.7M
FY22 HK$25.0M
FY23 −HK$2.6M
FY24 −HK$9.5M
FY25 −HK$4.1M

Is 2372 fairly valued? → Check now

Similar stocks

6 more Tobacco stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock Price Fair Value vs Fair Value
Philip Morris International Inc PM $182.95 $132.84 -27%
British American Tobacco p.l.c. BTI $61.12 $31.95 -48%
MO MO 1,253 MXN 1,090 MXN -13%
Altria Group PHM7 €60.20 €54.57 -9%
Japan Tobacco Inc JAPAF $40.34 $36.15 -10%
ITC Limited ITC ₹291.25 ₹291.49 +0%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is 2372 (2372) undervalued?
As of Jul 2, 2026, our model estimates a fair value of HK$0.3400 versus a price of HK$1.11 — about −69% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 2372?
Our model-based fair value for 2372 is HK$0.3400 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$1.11.
What is the quality score of 2372?
2372 has a Quality Score of 75/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of 2372 (2372)?
2372 reported trailing-twelve-month revenue of about HK$106M (latest available figure, as of Jul 2, 2026).
What is the net profit margin of 2372?
The net profit margin of 2372 is about -3.9%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.